Log in
Registration
Українська
English
Search for:
Home
Electronic publication
Fresh number
Archives
Authors
About Edition
Subscription
Requirements for authors
Reviewing
Editorial board
Organization of anticancer fight
Tumors of the chest cavity
Tumors of abdominal organs
Tumors of skin, soft tissues, bones
Breast tumor
Oncogynecology
Tumors of the head and neck
Oncurology
Oncohematology
Radiation diagnostics, radiation therapy
Experimental studies
Magazine online
All news
Contents of the journal : Т. 14, №4 (56)
A case from practice
Experience of management of breast cancer in pregnant patient of 28–29 weeks of gestation
Authors: Dronova V.L. Dronov O.I. Lyalkin S.A. Mokryk О.М.... Т. 14, №4 (56)
A rare form of renal cell cancer metastasis to the minor salivary gland: a clinical case
Authors: Antoniv R.R. Kostyshyn I.D. Girna G.A. Boyko V.V.... Т. 14, №4 (56)
Original Articles
The impact of tumor burden score on postoperative morbidity and survival in colorectal cancer patients with liver metastases
Authors: Burlaka A. Bezverhnyi V. Mykytyuk A. Dupyk M.... Т. 14, №4 (56)
Peculiarities of treatment of patients with laryngeal cancer
Authors: Lukach E.V. Serezhko Yu.O. Tsymbalyuk E.M. Т. 14, №4 (56)
Cost minimization analysis of neoadjuvant treatment of luminal B HER2/neu-negative breast cancer: chemotherapy versus hormone therapy
Authors: Artemenko M.V. Bondarenko I.M. Zavizion V.F. Avierin D.I. Т. 14, №4 (56)
Conducting mobilization courses and apheresis of CD34
+
. Experience of the Nonprofit Organization National Cancer Institute
Authors: Kryachok I.A. Raіnyk K.P. Shokun N.V. Burtna A.S. Т. 14, №4 (56)
Review Articles
Midazolam in modern anesthesiology and intensive care
Authors: Lisnyy I.I. Zakalska K.A. Т. 14, №4 (56)
Use of artificial intelligence in medicine, surgery, dentistry, and oncology
Authors: Svintsitskyi A.V. Klymova V.V. Sendetskyi S.S. Т. 14, №4 (56)
Advantages and risks of using CDK4/6 inhibitors, including palbociclib, in first-line therapy for HR+ metastatic breast cancer
Т. 14, №4 (56)
KEYNOTE-006 study: results of 10-year follow-up of pembrolizumab versus ipilimumab in advanced melanoma
Т. 14, №4 (56)
Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial
Т. 14, №4 (56)
Pembrolizumab
vs
Placebo as Adjuvant Therapy for High-Risk Stage II Melanoma: Long-Term Follow-Up, Rechallenge, and Crossover in KEYNOTE-716
Т. 14, №4 (56)
CLL in the context of evidence-based medicine: how do international guidelines align with Ukrainian practice?
Authors: Kryachok I.A. Tytorenko I.B. Moroz Y.V. Т. 14, №4 (56)
Topical
A Multidisciplinary Approach to Breast Cancer Treatment in Historical Perspective
Т. 14, №4 (56)